Literature DB >> 15543223

The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents.

D Molnár1.   

Abstract

OBJECTIVE: To review the prevalence of the metabolic syndrome and type 2 diabetes in children and adolescents.
METHOD: Literature review.
RESULTS: It is well demonstrated that cardiovascular risk factors are frequent in childhood obesity and they tend to cluster. However, the frequency of the metabolic syndrome in childhood and adolescence has been investigated only by few studies. In spite of the diverse criteria used for defining the metabolic syndrome, it is evident that the syndrome is already highly prevalent among obese children and adolescents. Population-based data suggest that the epidemic of pediatric obesity is being followed by an increase of type 2 diabetes mellitus, especially in the United States and in minorities. For the European countries, there are no population-based incidence and prevalence data concerning type 2 diabetes mellitus in children and adolescents. From the available data, the magnitude of the problem in the European Caucasian population seems to be much less than in North America.
CONCLUSION: There is an urgent need to establish internationally acceptable criteria for the metabolic syndrome in children and adolescents and to commence screening for this syndrome. Although type 2 diabetes mellitus is still rare among European children, screening is recommended for type 2 diabetes mellitus or impaired glucose tolerance in children and especially in adolescents with substantial risk for the development of this disease.

Entities:  

Mesh:

Year:  2004        PMID: 15543223     DOI: 10.1038/sj.ijo.0802811

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  19 in total

Review 1.  Modulation of food reward by adiposity signals.

Authors:  Dianne P Figlewicz; Amy MacDonald Naleid; Alfred J Sipols
Journal:  Physiol Behav       Date:  2006-11-29

Review 2.  Peroxisome proliferator activated receptor-alpha (PPARα) and PPAR gamma coactivator-1alpha (PGC-1α) regulation of cardiac metabolism in diabetes.

Authors:  Jennifer G Duncan
Journal:  Pediatr Cardiol       Date:  2011-02-02       Impact factor: 1.655

3.  Homeostatic model assessment (HOMA) index cut-off values to identify the metabolic syndrome in children.

Authors:  B Tresaco; G Bueno; I Pineda; L A Moreno; J M Garagorri; M Bueno
Journal:  J Physiol Biochem       Date:  2005-06       Impact factor: 4.158

Review 4.  A review of the treatment of type 2 diabetes in children.

Authors:  Erin St Onge; Shannon A Miller; Carol Motycka; Adrienne DeBerry
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jan-Feb

5.  Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity.

Authors:  Yasar Sen; Nurgun Kandemir; Ayfer Alikasifoglu; Nazli Gonc; Alev Ozon
Journal:  Eur J Pediatr       Date:  2008-01-17       Impact factor: 3.183

6.  Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function.

Authors:  Elaine M Urbina; Thomas R Kimball; Connie E McCoy; Philip R Khoury; Stephen R Daniels; Lawrence M Dolan
Journal:  Circulation       Date:  2009-05-26       Impact factor: 29.690

7.  Body mass index predicts insulin resistance in survivors of pediatric acute lymphoblastic leukemia.

Authors:  Stefanie Lowas; Suman Malempati; Daniel Marks
Journal:  Pediatr Blood Cancer       Date:  2009-07       Impact factor: 3.167

8.  High-normal fasting glucose levels are associated with increased prevalence of impaired glucose tolerance in obese children.

Authors:  A Grandone; A Amato; C Luongo; N Santoro; L Perrone; E Miraglia del Giudice
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

9.  Metabolic syndrome in Indian children - An alarming rise.

Authors:  M Ashraf Ganie
Journal:  Indian J Endocrinol Metab       Date:  2010-01

10.  Diagnostic criteria patterns of U.S. children with Metabolic Syndrome: NHANES 1999-2002.

Authors:  Sibylle Kranz; Lindsey J Mahood; David A Wagstaff
Journal:  Nutr J       Date:  2007-11-06       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.